Month: May 2020

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATESTORONTO, May 17, 2020 (GLOBE NEWSWIRE) — NEW WAVE HOLDINGS CORP. (the “Company” or “New Wave Holdings“) (CSE: SPOR) (FWB: 0XM2), (OTC:TRMND), is pleased to announce through it’s investment in Anahit Therapeutics Ltd. (“Anahit”), it has entered into a manufacturing agreement with Kirkman®, a FDA and GMP certified manufacturer to launch two proprietary functional mushroom products for the North American market.Kirkman is a leading manufacturer of nutritional supplements for individuals with dietary sensitivities and restrictions. The company was founded in 1949, making it one of the oldest supplement companies in its niche.“Kirkman has established itself as a leader in developing effective nutritional supplements...

The information in this press release is not intended for distribution, publication or public release, directly or indirectly, in or into, Australia, Canada, Japan, the United States or any other jurisdiction where the publication or distribution of this press release may be unlawful.  Please see the important notice at the end of this announcement.HOYLU PUBLISHES INFORMATION MEMORANDUMStockholm, May 17, 2020 – Hoylu AB (”Hoylu” or the ”Company”) has today published an information memorandum regarding the rights issue of approximately SEK 11 million (the “Rights Issue”) announced on May 6, 2020 by the Company.The information memorandum, including conditions and instructions for participation in the Rights Issue, is available at Hoylu’s website:https://www.hoylu.com/information-memorandum-may-2020-rights-issue/The information memorandum...

Informationen i detta pressmeddelande får inte offentliggöras, publiceras eller distribueras, direkt eller indirekt, i eller till, Australien, Kanada, Japan, USA eller något annat land där sådan publicering eller distribution skulle bryta mot tillämpliga lagar eller regler.  Se avsnittet viktig information i slutet av detta pressmeddelande.HOYLU OFFENTLIGGÖR INFORMATIONSMEMORANDUMStockholm 17 maj 2020 – Hoylu AB (”Hoylu” eller ”Bolaget”) offentliggör idag ett informationsmemorandum med anledning av den företrädesemission av aktier om cirka 11 miljoner kronor (”Företrädesemissionen”) som Bolaget offentliggjorde den 6 maj 2020.Informationsmemorandumet, inklusive villkor och anvisningar för emissionen, finns tillgängligt på Hoylus webbplats:https://www.hoylu.com/information-memorandum-may-2020-rights-issue/Informationsmemorandumet kommer...

OVERVIEW OF ECONOMIC ACTIVITIESMANAGEMENT COMMENTARYThe 3rd quarter of the financial year ended with a 2% sales growth for PRFoods, the total turnover was 18.5 million euros (9 months 63.2 million euros). 9-month EBITDA increased by 35% to 2 million euros and net loss decreased by 25% to 0.6 million euros compared to the same period last year.The end of the quarter brought a global pandemic to our key markets, and restrictions of the states of emergencies declared began to take effect. HoReCa restrictions and a drastic reduction in air transport had a significant impact on turnover as early as at the end of March. Also, as during any crisis, customers made changes to their food baskets in favour of cheaper products. PRFoods withstood the Covid-19 pandemic with a strengthened balance sheet, as we had just refinanced our short-term loans...

ÜLEVAADE MAJANDUSTEGEVUSESTMajandusaasta 3. kvartal lõppes PRFoodsile 2%-lise müügikasvuga, kokku oli käive 18,5 miljonit eurot (9 kuud 63,2 miljonit eurot).  9 kuu EBITDA kasvas 35% võrra 2 miljoni euroni ning puhaskahjum vähenes 25% võrra 0,6 miljoni euroni võrreldes eelmise aasta sama perioodiga.Kvartali lõpp tõi ülemaailmse pandeemia jõudmise meie põhiturgudele ning eriolukorraga seotud piirangud hakkasid avaldama mõju. HoReCa piirangud ning lennutranspordi drastiline vähenemine mõjutasid märkimisväärselt käivet juba märtsi lõpus. Samuti, nagu iga kriisi ajal, tegid kliendid oma toidukorvis muudatusi, eelistades odavamaid tooteid. PRFoods läks Covid-19 pandeemiale vastu tugevdatud bilansiga, kuna olime just refinantseerinud oma lühiajalised laenud võlakirjadega ning samuti oleme parandanud oma rahavoogusid tingituna väiksemast tooraine...

Company announcement no. 08 – 20 17 May 2020Change in the executive management of NTG Nordic Transport Group A/SThe board of directors of NTG Nordic Transport Group A/S (“NTG”) has with effect as of today decided to discontinue the contract between NTG and Mikkel Fruergaard as the basis for a mutual beneficial cooperation is deemed no longer to be present. Mikkel Fruergaard was member of the executive management of NTG with responsibility for its Air & Ocean division, until 1 May 2020 as Group co-CEO (reference is made to company announcement no. 02-20 dated 19 March 2020).The board wishes to thank Mikkel Fruergaard for his valuable contributions to NTG since he joined NTG in 2016, not least for his leading role in the successful listing of NTG last year.A direct replacement for Mikkel Fruergaard has not been designated, however,...

Looking for the best way to secure your retirement or investment portfolio? Check out this report to discover the best assets to invest in right now!Investments Buzz, an informative website specializing in high-quality investment resources, released an updated report on effective retirement portfolio diversification with precious metals and cryptocurrencies. The report offers an overview of the main benefits of gold and crypto investment and provides expert recommendations on the best platform to purchase such assets online. Go to http://investmentsbuzz.com for more info. The newly released report aims to provide anyone interested in effective investment strategies with a practical resource on how to protect their assets against increased market volatility.The current economic crisis brought about by the Covid-19 pandemic has led to a...

FCA Italy working on activation of credit facility, as provided under the recent Italian Liquidity Decree, to further support automotive sector in Italy·FCA Italy has initiated a process with the Italian Government to obtain a guarantee from SACE in support of a credit facility designed to help the automotive chain Italy, comprised of approximately 10,000 small and medium size businesses. A dialogue in that respect is ongoing with the first banking group in Italy, Intesa Sanpaolo.In relation to recent press speculation, FCA Italy S.p.A. (“FCA” or “the Company”) confirms that it is in talks with the Italian Government (the Ministry of Economy and Finance – MEF, and the Ministry of Economic Development – MISE) to obtain a guarantee from SACE, Italy’s Export Credit Agency (part of the Italian State’s Cassa...

HONOLULU, May 16, 2020 (GLOBE NEWSWIRE) — First Hawaiian, Inc. (NASDAQ: FHB) announced today that Robert Harrison, Chairman, President and CEO, Ravi Mallela, CFO, and Ralph Mesick, Chief Risk Officer, will participate in the 2020 Wells Fargo Virtual Financial Services Investor Forum held on May 20 and 21. The management team will participate in a fireside chat on Thursday, May 21, 2020 at 1:30 p.m. Eastern Time.  The live audio webcast of the fireside chat can be accessed through the following link:  https://cc.webcasts.com/well001/052020a_js/?entity=9_V55HEUE.  An archive of the audio webcast can be accessed using the same link, and will be available for 30 days after the event.About First HawaiianFirst Hawaiian, Inc. (NASDAQ:FHB) is a bank holding company headquartered in Honolulu, Hawaii.  Its principal subsidiary, First Hawaiian...

– Le MCLA-128, zenocutuzumab, une analyse épidémiologique indépendante confirme un potentiel clinique et commercial significatif dans le traitement des cancers à fusion NRG1 –– MCLA-117 démontre une activité clinique limitée dans l’essai de phase 1 –– Un vaste panel de nouveaux anticorps bispécifiques CD3 apporte des informations et des pistes pour maximiser la biologie d’activation des lymphocytes T –UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 16 mai 2020 (GLOBE NEWSWIRE) — Merus NV (Nasdaq : MRUS) (« Merus », la « Société », « nous » ou « notre »), une société d’oncologie au stade clinique qui développe des anticorps multispécifiques de pleine longueur innovants (Biclonics® et Triclonics™), a annoncé aujourd’hui l’acceptation de six résumés pour de prochains congrès médicaux sur le cancer. Quatre...